Research · head to head
STARLIMS vs Suzy

STARLIMS
Research
Laboratory information management from Abbott for regulated and public health labs
- From
- On request
- Rated
- -

Suzy
Research
Enterprise consumer insights on an owned US panel, resold elsewhere through Cint
- From
- On request
- Rated
- -
The short version
- Each has a real cost: STARLIMS implementation is lengthy and outcome quality depends heavily on the partner doing the configuration; Suzy the proprietary Crowdtap panel is US only at around a million consumers with roughly 50,000 verified active monthly, and everything international is resold Cint supply, so the speed and verification argument that justifies the price applies to one market.
- They diverge on capability: STARLIMS covers Sample and specimen management, Suzy covers Suzy Insights.
- Prices and features above were last checked on 31 August 2026.
Where they differ
Only the attributes on which STARLIMS and Suzy actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in STARLIMS
- Sample and specimen management
- Quality management
- Instrument integration
- Public health reporting
- Regulatory compliance
- Web and mobile access
Only in Suzy
- Suzy Insights
- Suzy Live
- Suzy Audiences
- Suzy Speaks
- Video open ends
- Advanced methods
- Data Explorer
- AI Decision Engine
What people use each for
The jobs each tool is most often brought in to do.
STARLIMS
- Public health laboratories handling surveillance and outbreak investigationnot Suzy
- Clinical laboratories needing regulated specimen tracking and reportingnot Suzy
- Food safety and environmental testing laboratoriesnot Suzy
- Multi-site laboratory networks standardising methods and specificationsnot Suzy
Suzy
- A US consumer packaged goods brand that needs concept testing back the same day because a packaging decision is due at the end of the week.not STARLIMS
- An insights department running an always-on brand tracker on a US audience without re-commissioning fieldwork every wave.not STARLIMS
- A team that wants quant screening followed immediately by moderated qual with the same respondents, rather than two vendors and two timelines.not STARLIMS
- A product team testing claims and price sensitivity with MaxDiff and conjoint on a panel they can go back to repeatedly.not STARLIMS
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
STARLIMS
- Implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
- Pricing is quote-based with no public reference, making early budget setting difficult
- The breadth across laboratory types means some verticals get less development attention than others
- Interface modernisation has lagged behind newer cloud-native laboratory platforms
- Over-specified for small laboratories, where a lighter LIMS delivers most of the value for a fraction of the effort
Suzy
- The proprietary Crowdtap panel is US only at around a million consumers with roughly 50,000 verified active monthly, and everything international is resold Cint supply, so the speed and verification argument that justifies the price applies to one market.
- Customers have asked Suzy to build proprietary panels with native speakers in Germany, France, Japan, India and Brazil, which confirms those do not exist today; multi-market brands need a second vendor and lose the single-source comparison.
- Reviewers report the panel skews female and millennial and falls short on Gen Z, male and various ethnic segments, and that niche or B2B audiences are hard to reach, so quota fills can be slow or impossible.
- Reviewers also raise data trust concerns about respondent sourcing and vetting, including one naming bot responses and acquiescence bias, which is the standing risk of any single owned opt-in panel with repeat respondents.
- Pricing is a sales-led annual commitment reported to run around $88,000 a year at the median with onboarding fees and per-seat charges on top, with no trial, no self-serve and no pay-per-response option, so there is no cheap way to validate fit.
- Credits are pre-committed monthly against forecast activity with no published overage rate, so under-use is wasted spend and a busy quarter triggers an unbudgeted purchase.
- Integrations are genuinely thin: there is no public integrations page and no public API documentation, and the only confirmed external data relationship is Cint, so expect to move data by export.
Pricing, plan by plan
STARLIMS
On request- STARLIMS$undefined/year
- Sample management
- Quality management
- Instrument integration
Suzy
On request- Suzy$undefined/year
- Annual subscription with pre-committed monthly research credits
- Credit volume set against forecast study activity
- Onboarding fees and per-seat charges quoted separately
Which should you pick?
Choose STARLIMS if
- You need sample and specimen management.
- You work on Web, Windows, Cloud, On-premise.
- You also want quality management.
Choose Suzy if
- You need suzy insights.
- You work on Web, iOS, Android.
- You also want suzy live.
Questions people ask
- Is STARLIMS or Suzy better?
- Neither clearly leads. STARLIMS starts at On request and Suzy at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, STARLIMS or Suzy?
- STARLIMS starts at On request and Suzy at On request.
- Does STARLIMS or Suzy run on more platforms?
- STARLIMS runs on Web, Windows, Cloud, On-premise. Suzy runs on Web, iOS, Android.
- What is STARLIMS best used for?
- STARLIMS is most often used for public health laboratories handling surveillance and outbreak investigation, clinical laboratories needing regulated specimen tracking and reporting, food safety and environmental testing laboratories, multi-site laboratory networks standardising methods and specifications. Of those, public health laboratories handling surveillance and outbreak investigation and clinical laboratories needing regulated specimen tracking and reporting are not what Suzy is typically brought in for.
- What can STARLIMS do that Suzy cannot?
- STARLIMS covers Sample and specimen management, Quality management, Instrument integration, Public health reporting. Suzy covers Suzy Insights, Suzy Live, Suzy Audiences, Suzy Speaks.
Answered from the vendors’ own pages
STARLIMS: Who owns STARLIMS?
Abbott. That gives it institutional weight in laboratory procurement and a natural relationship with Abbott diagnostic instruments.
Suzy: Is the panel global?
No. Crowdtap, the owned panel, is US only. International studies run on Cint supply, which you could contract for directly.
STARLIMS: Where is it strongest?
Public health and clinical laboratories. Surveillance reporting, outbreak investigation and unpredictable specimen surges are different problems from pharmaceutical QC, and it handles them well.
Suzy: What does it cost?
Nothing is published. Third-party analysis puts the median contract around $88,000 a year with a range roughly $34,000 to $187,500, plus onboarding and per-seat fees.
STARLIMS: What does it cost?
Not published. Enterprise licensing plus implementation, quoted on laboratory count, users and modules.
Suzy: Is there an API?
Nothing public. Suzy publishes no API documentation and no named connectors beyond Cint. Verify any integration requirement in the sales call before committing.
STARLIMS: How does it compare to LabWare?
Both are enterprise LIMS with regulatory depth. LabWare is more dominant in pharmaceutical QC; STARLIMS has more presence in public health and clinical. Implementation partner quality matters more than the platform difference.
Suzy: What changed in April 2026?
Suzy repositioned as an AI Decision Engine with Intelligence and Impact modules, while headcount fell from about 230 to 186. Ask how the roadmap is now split between that and the classic survey and qual products.
STARLIMS: What decides a successful implementation?
Configuration and validation quality, not platform features. Evaluations that compare feature lists rather than implementation approach are asking the wrong question.
Related pages
Other head to heads
- STARLIMS vs LabWare
- STARLIMS vs Thermo SampleManager LIMS
- STARLIMS vs LabVantage
- STARLIMS vs Benchling
- STARLIMS vs Sapio Sciences
- STARLIMS vs Labguru
- STARLIMS vs Scispot
- STARLIMS vs Medidata Rave
- STARLIMS vs Roam Research
- STARLIMS vs Contentsquare
- STARLIMS vs Castor EDC
- STARLIMS vs DNAnexus
- STARLIMS vs Terra
- STARLIMS vs TetraScience
- STARLIMS vs Valispace
- STARLIMS vs Wolfram Mathematica
- STARLIMS vs SurveyMonkey
- STARLIMS vs Attest
- STARLIMS vs Zappi
- STARLIMS vs Remesh
- STARLIMS vs GWI
- STARLIMS vs Aurelius
- STARLIMS vs Genedata
- STARLIMS vs Dovetail
- STARLIMS vs Zotero
- STARLIMS vs Elicit
- STARLIMS vs Mendeley
- Suzy vs LabWare
- Suzy vs Thermo SampleManager LIMS
- Suzy vs LabVantage
- Suzy vs Benchling
- Suzy vs Sapio Sciences
- Suzy vs Labguru
- Suzy vs Scispot
- Suzy vs Medidata Rave
- Suzy vs Roam Research
- Suzy vs Contentsquare
- Suzy vs Castor EDC
- Suzy vs DNAnexus
- Suzy vs Terra
- Suzy vs TetraScience
- Suzy vs Valispace
- Suzy vs Wolfram Mathematica
- Suzy vs SurveyMonkey
- Suzy vs Attest
- Suzy vs Zappi
- Suzy vs Remesh
- Suzy vs GWI
- Suzy vs Aurelius
- Suzy vs Genedata
- Suzy vs Dovetail
- Suzy vs Zotero
- Suzy vs Elicit
- Suzy vs Mendeley
